In the context of MSAF, routine FHR monitoring has been recommended to screen for early signs of fetal hypoxia. 4 Umstad 5 investigated the predictive value of abnormal FHR tracing pattern in early labour and found that the presence of meconium in the amniotic fluid improved the predictive properties of the test. In contrast, Steer et al. 6 investigated the interrelationships among abnormal CTG's in labour, MSAF, cord blood PH and Apgar scores among 1219 consecutive births. The presence of abnormal FHR tracings did not appear to modify the association between MSAF and adverse outcomes.
With the background of these conflicting results, further research is required to assess the relevance of FHR tracing abnormalities in the context of MSAF.
This study was designed to compare the pregnancy outcomes and the perinatal and early neonatal outcomes among patients with abnormal FHR tracings with or without MSAF.
METHODS
This study was conducted in the department of Obstetrics and Gynaecology, Institute of Maternal and Child Health, Government Medical College, Kozhikode. A total of 600 labouring women with evidence of presumed fetal jeopardy (either in the form of abnormal FHR tracing or MSAF or both) were enlisted. Analysis of their data concerning sociodemographic and obstetric characteristics were taken from their case records.
 Data regarding maternal and neonatal outcomes were obtained from clinical charts  Measures of pregnancy outcomes were mode of delivery, CD, indications for CD (% of CD for fetal distress), oligamnios, MSAF, cord around neck of fetus.
 Measures of neonatal outcomes were Apgar at 1' and 5' intervals, birth weight, requirement of resuscitation, NICU admissions for causes other than prematurity, duration of NICU stay, complications and perinatal mortality.
Inclusion criteria
Nulliparous/multiparous women with singleton, term gestation, in labour, cephalic presentation and a nonreassuring FHR tracing and/or MSAF as diagnosed by resident or attending staff.
Exclusion criteria
If there was a known or suspected fetal anomaly, chorioamnionitis, placenta previa, vaginal bleeding due to other causes, breech presentation, multiple pregnancy, acute hypoxia (like rupture uterus, abruption, cord prolapse) or an indication for urgent delivery.
We take an admission test and subsequently repeat the CTG when she's in labour.
A total of 600 labouring women who showed evidence of presumed fetal jeopardy either in the form of abnormal FHR tracing or MSAF or both were enlisted and followed till after delivery. 
Definition of abnormal tracings

RESULTS
Of the total 600 labouring patients enrolled in the study with presumed fetal jeopardy were divided into 3 groups. Table 1 shows the patient's sociodemographic and obstetrical characteristics according to FHR tracings.
The mean age of patients were 25.6 ± 4 years ranging from 18-35. Patients in above 30yrs age group had more of abnormal FHR tracings which may be due to associated comorbidities and obstetric complications.
Among the associated obstetric complications, preeclampsia, IUGR and oligamnios showed maximum correlation (those with abnormal FHR tracings had 43.6% incidence of associated obstetric medical complications, P = 0.002). Preeclampsia was seen in 32.9% of patients with presumed fetal jeopardy. Table 2 shows major abnormal FHR tracing patterns in the study group. Of which, 38% of ladies had decelerations (including late and variable), 30% of them had only tachycardia. 22% of laboring women showed only absence of accelerations with other parameters being normal. Table 3 illustrates the pregnancy outcomes in terms of mode of delivery in three study groups. The frequency of CD for fetal indication was maximum in patients with FHR tracing abnormalities, found to be statistically significant. 86.3% in those with MSAF and abnormal FHR tracing and 55.6% in those with clear liquor and abnormal FHR tracing. In those with MSAF and normal tracing, we had a CD rate of 53.4% which may be due to the fact they had other associated obstetric factors and were remote from delivery. Similarly, the proportion of abnormally big and small placentae was more with abnormal tracing group (12.9%) compared to normal tracing group (1%).
Compressed umbilical cord was found to be high among women with abnormal FHR tracing (14.6%) but not statistically significant.
MSAF was seen more associated with small placentae and decreased liquor. Table 5 shows the fetal outcomes. Birth weight was lower in abnormal FHR tracing group though not statistically significant and lower APGAR scores at 1' and 5' was significantly more in abnormal tracing groups with or without MSAF (82.5% versus17.4 % than normal tracing group (P <0.05).
Perinatal outcomes
More importantly, 49.6% of low APGAR scores were seen in those with clear liquor and abnormal FHR tracing (P = 0.00001).
The babies who needed immediate resuscitation and admission to NICU was higher in abnormal tracing group (76.74% versus 23.2%) which was statistically significant (P = 0.00001). In those labours complicated by MSAF, more babies in the group of abnormal tracing required admission to NICU and in 15 babies meconium was suctioned below cords.
The perinatal deaths were more in abnormal FHR tracing group (6 FSB and 28 NNDs) irrespective of nature of liquor. Those who had MSAF but normal tracings had no perinatal deaths and had better outcomes. Of the NNDs in the abnormal tracing group, 6 of them had congenital heart disease. There was no significant difference between the 3 groups of patients with MSAF and without MSAF and abnormal FHR tracing regarding the maternal age, parity and gestational age which was similar to studies such as Dellinger et al. 8 CTG showing only tachycardia had only 13.6% abnormal outcomes. It's the early sign of fetal distress. So, once interventions are done early, outcomes were good. In our study, in CTG showing decelerations, 84% had abnormal outcomes which are similar to studies done by Kubli et al., 9 Shifrin et al., 10 Keogen et al. 11 (Decelerations included all types -late and moderate to severe variable decelerations).
Abnormal outcomes were more seen in those who had preeclampsia, IUGR and oligamnios.
Regarding the mode of delivery, CD were more in those with MSAF and abnormal tracing which was similar to study by Dellinger et al. 8 and Katun et al. and Chauhan etal. 12 Perinatal outcomes, as seen, low APGAR scores were more in those with abnormal FHR tracing (with or without MSAF) and subsequent NICU admissions were also more in this group which was similar to many studies mainly Dellinger et al. 8 Convulsions, possibly due to HIE were seen in those with abnormal tracing when compared to those with normal FHR tracing. Of perinatal deaths, still births and NNDs were seen only in the abnormal FHR tracing group. Other authors have failed to demonstrate an association between FHR tracing abnormality &adverse neonatal outcomes in the presence of meconium staining. 6, 13 20 deaths were following vaginal delivery possibly due to delay in delivery.
CONCLUSION
A reassuring FHR pattern strongly predicts a good outcome for the neonate and management options for labour can be presented to the patient.
EFM reduces hypoxia related deaths by 60% which translates into the prevention of 1 perinatal death per 1000 births at the expense of an increase in operative vaginal and CD for non-reassuring fetal status by a factor of 2-3.
14 In summary, in the presence of MSAF, nonreassuring fetal heart rate patterns are associated with an increase in perinatal mortality and neonatal morbidity compared with patients with normal tracings. Non-reactive tracings in the background of normal liquor also carries a higher perinatal risk. Hence a need for caution in situations where we come across a non-reassuring tracing and should be managed accordingly on the background of the clinical scenario.
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